| |
 |
|
| | |
Discussion forum - BSH 2020 VIRTUAL
 Topic - Lymphoma/CLL
If you are already registered in PosterSessionOnline, enter your e-mail and click on LOGIN. Otherwise click on REGISTER. |
|
|
| | |
|
|
|
|
Poster: 86
Visits: 37
Title: Addition of bendamustine to Brentuximab vedotin leads to improved complete metabolic remission rates in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective, single centre series
Authors: Annabel Mcmillan , A. T. ONeill, W. Townsend, A. Virchis, J. Lambert, K. Von Both, L. Menezes, P. Humphries, B. Carpenter, V. Grandage, R. Hough, K. M. Ardeshna, and S. Daw
Centre:
|
|
You must be registered to reply or comment.
|
|
ADDITION OF BENDAMUSTINE TO BRENTUXIMAB VEDOTIN LEADS TO IMPROVED COMPLETE METABOLIC REMISSION RATES IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS WITH RELAPSED AND REFRACTORY CLASSICAL HODGKIN LYMPHOMA: A RETROSPECTIVE, SINGLE CENTRE SERIES
|
|
| You must be registered to reply or comment. |
|
|
|
|
|
|
| Most viewed poster for this congress |
|
|
Poster: 1
Visits: 536
Title: Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial
Authors: Daniel Leongamornlert , E. Barretta, S. Lee, T. Creasey, R. Mitchell, A. A. Kirkwood, L Clifton-Hadley, P. Patrick, P. Campbell, B. Patel, A. Moorman, A. K. Fielding, E. Papaemmanuil
Centre:
|
|
|
|
|
|
|
| Poster most viewed in this topic |
|
|
Poster: 81
Visits: 112
Title: Updated Results of a Phase Ib/II Randomised Study: Polatuzumab Vedotin (Pola) Plus Bendamustine (B) and Rituximab (R) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
Authors: Elaine Kamara , L.H. Sehn, M.J. Matasar, C.R. Flowers, M. Kamdar, A.K. McMillan, M. Hertzberg, S. Assouline, T.M. Kim, W.S. Kim, M. Ozcan, B. Croft, J. Hirata, J. Cheng, G. Ku, A.F. Herrera
Centre:
|
|
|
|
